Page last updated: 2024-10-24

carmustine and Angiitis

carmustine has been researched along with Angiitis in 2 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenberg, HS1
Ensminger, WD1
Chandler, WF1
Layton, PB1
Junck, L1
Knake, J1
Vine, AK1
Savage, CO1
Pottinger, BE1
Gaskin, G1
Pusey, CD1
Pearson, JD1

Other Studies

2 other studies available for carmustine and Angiitis

ArticleYear
Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.
    Journal of neurosurgery, 1984, Volume: 61, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Carmustine; Female; Glioma; Humans; Injections, Intra-Arterial; Male;

1984
Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells.
    The American journal of pathology, 1992, Volume: 141, Issue:2

    Topics: Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antibody Formation; Autoantibodies;

1992